Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

January 18, 2022 09:00 ET | Source: Vivacitas Oncology Inc

Vivacitas Oncology to Present a Poster on AR-67 at the 3rd Annual Glioblastoma Drug Development Summit

WALNUT CREEK, Calif., Jan. 18, 2022 (GLOBE NEWSWIRE) -- Vivacitas Oncology, Inc., a privately-held oncology company focused on tough-to-treat cancers, will be attending and presenting a poster on...
January 17, 2022 09:00 ET | Source: Vivacitas Oncology Inc

Dr. Erkut Borazanci, MD, Joins Vivacitas Oncology's Pancreatic Medical Advisory Board

WALNUT CREEK, Calif., Jan. 17, 2022 (GLOBE NEWSWIRE) -- Vivacitas Oncology, Inc., a privately-held oncology company focused on tough-to-treat cancers, proudly announces that Dr. Erkut Borazanci, MD,...
November 22, 2021 12:30 ET | Source: Vivacitas Oncology Inc

Vivacitas Oncology, Inc. to Present on AR-67 at the Annual 5th Meridian Clinical Trials Conference

WALNUT CREEK, Calif., Nov. 22, 2021 (GLOBE NEWSWIRE) -- Vivacitas Oncology, Inc., a privately-held oncology company focused on tough-to-treat cancers, will present its lead development candidate,...
November 13, 2018 16:37 ET | Source: National Brain Tumor Society

National Brain Tumor Society Supported Work Features in 19 Presentations at 2018 Society for Neuro-Oncology Annual Meeting

Boston, MA, Nov. 13, 2018 (GLOBE NEWSWIRE) -- National Brain Tumor Society (NBTS), the largest nonprofit dedicated to the brain tumor community in the United States, today announced that its funded...
May 18, 2018 16:57 ET | Source: National Brain Tumor Society

National Brain Tumor Society Brings Realities of Glioblastoma to Congress

Washington, D.C., May 18, 2018 (GLOBE NEWSWIRE) -- National Brain Tumor Society (NBTS), the largest nonprofit dedicated to the brain tumor community in the United States, held a congressional...